8EJF
Structure of lineage V Lassa virus glycoprotein complex (strain Soromba-R)
8EJF の概要
| エントリーDOI | 10.2210/pdb8ejf/pdb |
| EMDBエントリー | 28179 28180 28181 28184 |
| 分子名称 | Glycoprotein GP1, Glycoprotein GP2, alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (7 entities in total) |
| 機能のキーワード | glycoprotein complex, lassa mammarenavirus, lasv, gpc, immune system, viral fusion protein, lassa virus, lineage v, soromba-r, viral protein |
| 由来する生物種 | Lassa mammarenavirus 詳細 |
| タンパク質・核酸の鎖数 | 6 |
| 化学式量合計 | 239234.59 |
| 構造登録者 | |
| 主引用文献 | Perrett, H.R.,Brouwer, P.J.M.,Hurtado, J.,Newby, M.L.,Liu, L.,Muller-Krauter, H.,Muller Aguirre, S.,Burger, J.A.,Bouhuijs, J.H.,Gibson, G.,Messmer, T.,Schieffelin, J.S.,Antanasijevic, A.,Boons, G.J.,Strecker, T.,Crispin, M.,Sanders, R.W.,Briney, B.,Ward, A.B. Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies. Cell Rep, 42:112524-112524, 2023 Cited by PubMed Abstract: Lassa fever is an acute hemorrhagic fever caused by the zoonotic Lassa virus (LASV). The LASV glycoprotein complex (GPC) mediates viral entry and is the sole target for neutralizing antibodies. Immunogen design is complicated by the metastable nature of recombinant GPCs and the antigenic differences among phylogenetically distinct LASV lineages. Despite the sequence diversity of the GPC, structures of most lineages are lacking. We present the development and characterization of prefusion-stabilized, trimeric GPCs of LASV lineages II, V, and VII, revealing structural conservation despite sequence diversity. High-resolution structures and biophysical characterization of the GPC in complex with GP1-A-specific antibodies suggest their neutralization mechanisms. Finally, we present the isolation and characterization of a trimer-preferring neutralizing antibody belonging to the GPC-B competition group with an epitope that spans adjacent protomers and includes the fusion peptide. Our work provides molecular detail information on LASV antigenic diversity and will guide efforts to design pan-LASV vaccines. PubMed: 37209096DOI: 10.1016/j.celrep.2023.112524 主引用文献が同じPDBエントリー |
| 実験手法 | ELECTRON MICROSCOPY (3.72 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






